Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), covering 2024-07-25 to 2024-07-25. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination [Phase 3]